Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Source: Thailand Medical News  Nov 29, 2019  4 years, 1 week, 3 days, 1 hour, 6 minutes ago

US FDA Approves New Dementia Treatment Patch, SID710

US FDA Approves New Dementia Treatment Patch, SID710
Source: Thailand Medical News  Nov 29, 2019  4 years, 1 week, 3 days, 1 hour, 6 minutes ago
The US FDA (Food and Drug Administration) has approved South Korean company SK Chemicals’ patch-type Alzheimer’s drug, SID710.

The drug which has already secured approval in the European Union in 2013, is the generic version of Novartis’ Exelon Patch for the treatment of dementia symptoms associated with Alzheimer’s disease.
The approval marks the first time a South Korean pharmaceutical company has applied to the US regulator for an Alzheimer’s patch on its own and secured it.
 “It is meaningful that SK Chemicals’ high technology skill was acknowledged through the FDA approval.”commented SK Chemicals CEO Dr Jeon Kwang-hyun in a phone interview with Thailand Medical News.
Dr Kwang-hyun added that the company are aiming to distribute the product into the South American and Southeast Asian markets.
At the moment, SID710 is being sold in 19 countries including Australia and Canada, was developed independently by SK Chemicals in 2010.
SID710 is a drug, which contains rivastigmine and  it supports patients with Alzheimer’s disease who mostly fail to take their medicine and face difficulties in swallowing tablets to attach the patch on the skin once a day for continuous delivery to the body.
Typically, patients should use the patch only once a day. However, the drug’s efficacy is similar to other oral medications.
The dementia treatment has been sold in Korea under the brand Wondron patch since 2014.
Eversince  the establishment of Sunkyung Textiles in 1969, SK chemicals has expanded into a chemical and life sciences enterprise representing South Korea.
The Korean company’s life sciences business is dominated by pharmaceuticals and biotech. It is anchored by healthcare solutions that cover patient care from diagnosis to treatment and prevention.


Jun 10, 2023  6 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news